Articles tagged with Drug Safety
Comprehensive exploration of living organisms, biological systems, and life processes across all scales from molecules to ecosystems. Encompasses cutting-edge research in biology, genetics, molecular biology, ecology, biochemistry, microbiology, botany, zoology, evolutionary biology, genomics, and biotechnology. Investigates cellular mechanisms, organism development, genetic inheritance, biodiversity conservation, metabolic processes, protein synthesis, DNA sequencing, CRISPR gene editing, stem cell research, and the fundamental principles governing all forms of life on Earth.
Comprehensive medical research, clinical studies, and healthcare sciences focused on disease prevention, diagnosis, and treatment. Encompasses clinical medicine, public health, pharmacology, epidemiology, medical specialties, disease mechanisms, therapeutic interventions, healthcare innovation, precision medicine, telemedicine, medical devices, drug development, clinical trials, patient care, mental health, nutrition science, health policy, and the application of medical science to improve human health, wellbeing, and quality of life across diverse populations.
Comprehensive investigation of human society, behavior, relationships, and social structures through systematic research and analysis. Encompasses psychology, sociology, anthropology, economics, political science, linguistics, education, demography, communications, and social research methodologies. Examines human cognition, social interactions, cultural phenomena, economic systems, political institutions, language and communication, educational processes, population dynamics, and the complex social, cultural, economic, and political forces shaping human societies, communities, and civilizations throughout history and across the contemporary world.
Fundamental study of the non-living natural world, matter, energy, and physical phenomena governing the universe. Encompasses physics, chemistry, earth sciences, atmospheric sciences, oceanography, materials science, and the investigation of physical laws, chemical reactions, geological processes, climate systems, and planetary dynamics. Explores everything from subatomic particles and quantum mechanics to planetary systems and cosmic phenomena, including energy transformations, molecular interactions, elemental properties, weather patterns, tectonic activity, and the fundamental forces and principles underlying the physical nature of reality.
Practical application of scientific knowledge and engineering principles to solve real-world problems and develop innovative technologies. Encompasses all engineering disciplines, technology development, computer science, artificial intelligence, environmental sciences, agriculture, materials applications, energy systems, and industrial innovation. Bridges theoretical research with tangible solutions for infrastructure, manufacturing, computing, communications, transportation, construction, sustainable development, and emerging technologies that advance human capabilities, improve quality of life, and address societal challenges through scientific innovation and technological progress.
Study of the practice, culture, infrastructure, and social dimensions of science itself. Addresses how science is conducted, organized, communicated, and integrated into society. Encompasses research funding mechanisms, scientific publishing systems, peer review processes, academic ethics, science policy, research institutions, scientific collaboration networks, science education, career development, research programs, scientific methods, science communication, and the sociology of scientific discovery. Examines the human, institutional, and cultural aspects of scientific enterprise, knowledge production, and the translation of research into societal benefit.
Comprehensive study of the universe beyond Earth, encompassing celestial objects, cosmic phenomena, and space exploration. Includes astronomy, astrophysics, planetary science, cosmology, space physics, astrobiology, and space technology. Investigates stars, galaxies, planets, moons, asteroids, comets, black holes, nebulae, exoplanets, dark matter, dark energy, cosmic microwave background, stellar evolution, planetary formation, space weather, solar system dynamics, the search for extraterrestrial life, and humanity's efforts to explore, understand, and unlock the mysteries of the cosmos through observation, theory, and space missions.
Comprehensive examination of tools, techniques, methodologies, and approaches used across scientific disciplines to conduct research, collect data, and analyze results. Encompasses experimental procedures, analytical methods, measurement techniques, instrumentation, imaging technologies, spectroscopic methods, laboratory protocols, observational studies, statistical analysis, computational methods, data visualization, quality control, and methodological innovations. Addresses the practical techniques and theoretical frameworks enabling scientists to investigate phenomena, test hypotheses, gather evidence, ensure reproducibility, and generate reliable knowledge through systematic, rigorous investigation across all areas of scientific inquiry.
Study of abstract structures, patterns, quantities, relationships, and logical reasoning through pure and applied mathematical disciplines. Encompasses algebra, calculus, geometry, topology, number theory, analysis, discrete mathematics, mathematical logic, set theory, probability, statistics, and computational mathematics. Investigates mathematical structures, theorems, proofs, algorithms, functions, equations, and the rigorous logical frameworks underlying quantitative reasoning. Provides the foundational language and tools for all scientific fields, enabling precise description of natural phenomena, modeling of complex systems, and the development of technologies across physics, engineering, computer science, economics, and all quantitative sciences.
Long-term prescription opioid use increased significantly from 1.8% to 5.4% between 1999-2000 and 2013-2014, associated with poorer physical health and concurrent benzodiazepine use.
Many pregnant women rely on the internet for medication safety information due to limited guidance from healthcare providers. Online searches reveal that health service sites are the most common source of information, with e-pharmacies being less frequently used.
Researchers found that licorice extracts from three species can inhibit certain liver enzymes involved in drug metabolism, potentially causing interactions with medications. The team plans to develop a safe and effective licorice therapy using a specific species, G. glabra, for women experiencing menopausal symptoms.
A new technique uses a fluorescent sensor to detect stress on cells at earlier stages than conventional methods. The method can be adapted to detect protein aggregates caused by other toxins and diseases such as Alzheimer's or Parkinson's.
Researchers found a 1% increase in undocumented immigration is associated with 22 fewer drug arrests and 42 fewer drunken driving arrests. The frequency of drunken driving fatalities was unaffected by unauthorized immigration rates.
Experts argue that stopping antibiotics sooner is a safe and effective way to reduce antibiotic overuse, contradicting the long-held 'complete the course' message.
Researchers developed a novel, tough, and triggerable hydrogel material that addresses safety concerns of traditional swallowable drug delivery systems. The new material can withstand gastrointestinal forces and release medication in a controlled manner.
Researchers created a system that uses continuous flow technology to produce pharmaceutical compounds, improving safety and yield. The new approach yielded 24 kilograms of chemotherapy agent prexasertib over three days, demonstrating its effectiveness.
A new research design from Perelman School of Medicine scientists provides a more effective way to assess the safety of newly approved drugs and those with rapidly increasing or declining use. This trend-in-trend method can identify rare side effects and provide accurate results, even in the absence of comparable control groups.
A new cost-benefit analysis suggests that a supervised facility in Baltimore could generate $7.8 million in annual savings by reducing overdose deaths, HIV and hepatitis C infections, hospitalizations and bringing people into treatment. The study found that such a space would save thousands of lives and prevent numerous overdoses.
A new nanofluidic device enables rapid testing of protein drugs produced by living cells, offering continuous monitoring and automated quality control. The system can analyze small protein samples in 30-40 minutes, with potential future miniaturization for real-time point-of-care checks.
Researchers found no evidence of increased risk of heart attack, depression, or self-harm in patients with COPD using varenicline. The medication is considered highly effective in helping smokers quit, addressing long-standing concerns among doctors.
Between 2001 and 2010, nearly a third of FDA-approved pharmaceuticals and biologics experienced postmarket safety events. These events, including withdrawals and boxed warnings, affect patient care and decision-making. Postmarket risks are often only apparent in larger patient populations and longer durations.
A Yale University study found that 32% of new drugs were flagged for a safety issue after approval, with biologic therapies and accelerated approvals being more likely to be associated with concerns. The findings highlight the need for ongoing surveillance of new drugs in the post-market period.
A study found that nearly 1 in 3 FDA-approved drugs had postmarket safety events, with biologics and psychiatric disease treatments being most affected. The study highlights the need for ongoing safety monitoring of approved medications.
Research suggests that pharmaceutical promotion can lead to overprescription of brand-name medications. The study found that top-selling and top-prescribed drugs were more likely to be effective, safe, affordable, novel, and represent a genuine advance in treating a disease. However, heavily promoted drugs often fell short in these areas.
A review of psychoactive substance use among healthy individuals highlights potential cognitive enhancements, but also safety concerns and ethical issues. The study suggests that more research is needed to understand the long-term effects and develop harm reduction strategies.
Researchers are developing new CT and MRI scan techniques to identify early signs of drug-induced liver and lung disease, potentially saving time and money. The TRISTAN project will use imaging biomarkers to develop predictive models for safer drug development.
Research links common painkillers diclofenac and ibuprofen to increased risk of cardiac arrest, with diclofenac being the most hazardous. The study advises limiting ibuprofen to 1200mg per day and avoiding diclofenac in patients with cardiovascular disease or high-risk factors.
Three experts from the University of Sydney argue that deregulating the FDA's regulatory system will subject patients to potentially toxic drugs. They highlight examples of successful drugs that were identified through well-controlled studies, and contrast these with unregulated markets that struggle to sift out ineffective treatments.
Researchers at the University of Alberta have discovered a molecule that works to restore balance to pathways responsible for chronic and acute heart failure. The new drug, developed through genetic mapping technology, has shown safety and efficacy in phase II clinical trials.
Physicians should be informed about herbal medications used by heart disease patients, as their efficacy and safety are rarely proven. Discussing the pros and cons of herbal medications is crucial for effective patient counseling.
The updated guidelines include two new medications approved by the FDA as safe and effective treatments for heart failure in women. WomenHeart sees these guidelines as an important addition to treatment efforts to achieve positive outcomes for women with the disease.
Researchers developed a cardiac safety index to rank commonly used chemotherapy drugs based on their likelihood of causing lasting heart damage in patients. They found that some drugs known to be particularly dangerous had the lowest safety indices, while better-tolerated ones ranked higher.
Experts recommend that laws legalizing marijuana outline restrictions on age, frequency of use, potency, and advertising to prevent abuse. They also emphasize the need for additional research to guide informed policy decisions.
The University of Liverpool is coordinating a £14m European research project, TransQST, to improve drug safety by leveraging public and private data. The project aims to develop novel computational models to address off-target reactions and minimize harm from adverse drug reactions.
Researchers propose creating a phased regulatory system for autonomous vehicles, mirroring the drug approval process to ensure safety and reliability. This approach would involve pre-clinical trials, in-human studies, and monitored testing before easing restrictions.
A novel sulfur-containing molecule has been identified with potent anticandidal activity, offering a new lead for designing effective drugs against Candida species. This discovery highlights the potential of endophytes as a source of bioactive compounds for developing novel medicines.
Researchers developed a more accurate system for predicting chemical toxicity, increasing accuracy to 85%, which could save millions of dollars and years of development time for new drugs. The system uses statistical analysis and QSAR modeling to assign numerical values to the accuracy of structural alerts.
Research finds generic cancer drugs are generally safe in countries with robust regulatory programs, but safety is uncertain in those with weaker oversight. In the US, economic studies show price savings from generics are limited by high review costs and lack of competition.
A simple instruction sheet significantly increases patient compliance with preoperative medication instructions, reducing errors by 40%. The intervention has been found to improve patient safety and comfort, while also limiting surgical cancellations.
Researchers discovered eight pairs of drugs associated with a higher risk of long QT syndrome, which can cause abnormal heart rhythms and sudden death. The study used big data mining to identify the interactions, and found that ceftriaxone and lansoprazole increased the risk by 1.4 times.
Researchers are working to develop safer drug treatments for newborns through increased clinical trials and improved efficiency. Currently, most medication treatments in newborns are based on adult studies, which can lead to uncertainty about their effectiveness.
A Mayo Clinic study found that NOACs dabigatran, rivaroxaban, and apixaban are at least as effective as warfarin in preventing stroke in atrial fibrillation patients. However, apixaban was associated with lower major bleeding rates, while rivaroxaban had a higher risk of serious bleeding.
Research reveals that 56% of people aged 90 and above with Alzheimer's disease rely on antipsychotics and antidepressants, highlighting the need for regular assessment of drug use in older adults. In contrast, those without Alzheimer's disease used these medications less frequently.
A new study reveals that spontaneous reports of adverse drug reactions in newborns and infants are insufficient, highlighting the need for additional reporting strategies. The UK's Yellow Card Scheme, established over 50 years ago, has improved drug safety but may not be enough to capture all instances of adverse reactions.
The European Medicines Agency's approval process for biosimilars shows variability, but offers insights into implementation. Regulators must balance the need for safety with flexibility to support innovation in new therapies, including personalized treatments and products on the borderline between medicines and other sectors.
A combination of formoterol and budesonide found to be safe and effective in treating moderate to severe asthma, with a lower risk of exacerbations than single-therapy budesonide. The therapy showed no significant increase in serious adverse events, providing reassurance for healthcare providers.
The PRAGUE-18 trial found prasugrel and ticagrelor to be equally safe and effective for treating ST-Elevation Myocardial Infarction (STEMI) patients. The study randomized 1,230 STEMI patients to receive either prasugrel or ticagrelor prior to primary percutaneous coronary intervention (pPCI).
A significant number of patients on clopidogrel therapy are also prescribed proton pump inhibitors (PPIs) omeprazole or esomeprazole, increasing the risk of cardiovascular events. Despite regulatory warnings, many physicians have continued to prescribe this combination.
A new study suggests that generic biologic drugs are as safe and effective as their brand-name counterparts, offering a cheaper alternative for consumers and the healthcare system. The findings have significant implications for the pharmaceutical market, with wide adoption of biosimilars expected to save billions of dollars.
A Perspective article highlights the importance of including medication purpose on prescriptions to enhance safety, prescribe appropriately, and improve convenience. By recording indications, clinicians can reduce errors, enable patients to better understand their regimens, and identify therapeutic alternatives.
A new study found that deutetrabenazine significantly improved chorea control in adults with Huntington disease. The treatment also showed improvements in impression of change and physical functioning, but not on balance tests.
A new study found that community pharmacy staff deviate from standard procedures to provide tailored patient care, citing high workload and conflicting pressures. The research highlights the tension between standardizing practice and delivering effective patient care.
A recent survey by Johns Hopkins Bloomberg School of Public Health found that more than half of patients prescribed opioids have leftover pills, with many saving them for future use. The study also revealed that nearly half of respondents received no information on safe storage and disposal of their medications.
A new drug called ixekizumab has shown significant promise in treating moderate to severe psoriasis, with 80 percent of patients experiencing complete or near-complete clearance of their symptoms. The long-term efficacy and safety of the treatment will be monitored closely.
Research reveals pregnant women often avoid medication due to perceived risks, with UTIs being a significant concern. Women's fears and beliefs about medication use during pregnancy highlight the need for better information and training for pharmacists.
A new investigational drug propiverine hydrochloride has shown promising results in treating overactive bladder, demonstrating better efficacy than an existing medication in reducing voiding frequency and incontinence episodes. Patients reported significant improvement in symptoms after treatment, with response rates increasing over time.
A review of nine observational studies found antipsychotic drug users nearly twice as likely to experience a heart attack as non-users. Patients with schizophrenia and those taking the drugs for less than 30 days had even higher risks.
Despite federal legislation, Yale researchers found that shortages for acute-care drugs used to treat critically ill patients have increased since the passage of FDASIA. The median duration of these shortages was approximately eight months, posing risks of medical error and reduced effectiveness.
A large trial of over 8000 participants found no significant increase in neuropsychiatric side effects with varenicline or bupropion. Varenicline was shown to be more effective in helping people stop smoking than other treatments, with similar efficacy across smokers with and without psychiatric disorders.
Research finds that proton pump inhibitors, widely used for heartburn and ulcers, can lead to kidney function decline, chronic kidney disease, and kidney failure. Long-term use of these medications significantly increases the risk of developing kidney problems.
Researchers at University of Queensland have developed a new plant-derived drug, T20K, that can block the progression of multiple sclerosis. The treatment, extracted from the Oldenlandia affinis plant, has shown success in an animal model and may offer a new quality of life for people with the debilitating disease.
A significant association has been found between HLA-B*59:01 and Clozapine-induced agranulocytosis and granulocytopenia, suggesting the allele may serve as a marker for prioritizing patients at low risk of developing these severe side effects. Further analysis is needed to clarify the mechanism behind this association.
A new drug, Arimoclomol, has shown promise against muscle wasting disease inclusion body myositis (IBM) by reversing key symptoms in mice and improving muscle strength. A patient safety trial also found the drug to be safe and well-tolerated.
A study found that white patients and those with lower incomes were slower to discontinue diabetes medication rosiglitazone after a FDA safety alert. Patients living in higher- versus lowest-socioeconomic status communities discontinued the drug significantly earlier.
A new article explores the effect of frailty on diabetes in older people, suggesting a regressive course with increased risk of hypoglycemia. The review highlights the importance of regular medication reviews and gradual reduction or withdrawal of hypoglycemic medications.
Researchers have identified an effective and safe treatment for Huntington's disease, using IONIS-HTTRx to inhibit huntingtin protein production. The drug has shown promising results in mice and monkeys, with motor skill improvements and reduced cortical huntingtin levels.
Researchers at Queen Mary University of London have discovered that the antimalarial drug Artesunate can reduce organ failure following injury in rats. The study's findings suggest that Artesunate could be a highly effective option for treating major trauma patients, particularly those experiencing hemorrhagic shock.
Researchers found liraglutide, a promising diabetes drug, can lead to pancreatic beta cell burnout in mice after six months of high-dose treatment. The study highlights the need for further investigation into the potential risks of this medication.